Arkadiusz Dudek
Chief Executive Officer at Ttc Oncology LLC
Profile
Arkadiusz Dudek is currently an Independent Director at SquareX Pharmaceuticals Corp., Chief Medical Officer at Luminary Therapeutics, Inc., and PSD, Chief Executive 2015 & Medical Officer at Ttc Oncology LLC.
He previously worked as a Director at Martell Diagnostic Laboratories, Inc. from 2014 to 2021 and as Chief Medical Officer at Vanquish Oncology, Inc. from 2013 to 2020.
Dudek earned a doctorate degree from the University of Warsaw.
Arkadiusz Dudek active positions
| Companies | Position | Start |
|---|---|---|
SquareX Pharmaceuticals Corp.
 SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Director/Board Member | 2017-12-31 |
| Ttc Oncology LLC | Chief Executive Officer | 2014-12-31 |
Luminary Therapeutics, Inc.
 Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN. | Chief Tech/Sci/R&D Officer | 2018-12-31 |
Former positions of Arkadiusz Dudek
| Companies | Position | End |
|---|---|---|
Martell Diagnostic Laboratories, Inc.
 Martell Diagnostic Laboratories, Inc. Medical SpecialtiesHealth Technology Martell Diagnostic Laboratories, Inc. engages in the operation of a reference laboratory that focuses on the development and promotion of tumor biomarker tests. It supports medical oncologists for managing cancer treatment. The company was founded by Frank Pass and is headquartered in Roseville, MN. | Director/Board Member | 2020-12-31 |
Vanquish Oncology, Inc.
 Vanquish Oncology, Inc. Pharmaceuticals: MajorHealth Technology Vanquish Oncology, Inc. operates as a drug development company. It focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets. The company was founded by Paul J. Hergenrother, Mike Handley and Ted Tarasow and is headquartered in Champaign, IL. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Training of Arkadiusz Dudek
| University of Warsaw | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Martell Diagnostic Laboratories, Inc.
Martell Diagnostic Laboratories, Inc. Medical SpecialtiesHealth Technology Martell Diagnostic Laboratories, Inc. engages in the operation of a reference laboratory that focuses on the development and promotion of tumor biomarker tests. It supports medical oncologists for managing cancer treatment. The company was founded by Frank Pass and is headquartered in Roseville, MN. | Health Technology |
Vanquish Oncology, Inc.
Vanquish Oncology, Inc. Pharmaceuticals: MajorHealth Technology Vanquish Oncology, Inc. operates as a drug development company. It focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets. The company was founded by Paul J. Hergenrother, Mike Handley and Ted Tarasow and is headquartered in Champaign, IL. | Health Technology |
Luminary Therapeutics, Inc.
Luminary Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN. | Commercial Services |
SquareX Pharmaceuticals Corp.
SquareX Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Squarex Pharmaceutical Corp. engages in the research and development of pharmaceutical products. It focuses on the late-clinical-stage drug that is intended to improve immune function to reduce severity and incidence of infectious disease. The company was founded on June 26, 2012 and is headquartered in St. Paul, MN. | Health Technology |
| Ttc Oncology LLC |
- Stock Market
- Insiders
- Arkadiusz Dudek